The FDA determined that Novo Nordisk’s obesity and diabetes drugs are no longer in short supply. Elsewhere, Concentra made a ...
Prescription totals for Attruby, which is locked in a closely watched commercial battle with Pfizer’s tafamidis, have more ...
Approval could come rather soon. Before market open, Biohaven announced that the U.S. Food and Drug Administration (FDA) had accepted its New Drug Application (NDA) for troriluzole. This is a once ...
Biohaven (BHVN) is jumping 10% after the FDA agreed to review the company's potential treatment for a rare disease. The FDA's Decision on BHVN's Drug Candidate The FDA agreed to review BHVN's ...
Troriluzole has a well-established safety profile and if approved, would be the first and only FDA-approved treatment for SCA; subject to receipt of FDA approval, Biohaven is prepared to ...
Pfizer has agreed to pay $59,746,277.54, plus interest, to resolve allegations that Biohaven knowingly submitted or caused false claims to be submitted to Medicaid and other federal health care ...
Other recent buys include Biohaven for US$11.6bil and Arena Pharmaceuticals for US$6.7bil. In May, Pfizer embarked on a cost-cutting plan meant to save US$1.5bil by the end of 2027. Still ...
Tong’s office said Pfizer had agreed to pay the sum on behalf of New Haven-based Biohaven to resolve allegations that Biohaven had knowingly submitted or caused to be submitted false claims to ...
Second, the returns on invested capital from Pfizer’s $11 billion Biohaven transaction have also already exceeded the most optimistic internal estimates, with Nurtec sales growing exponentially ...
Florida's Medicaid Fraud Control Unit secured the win through a multistate action. Pharmaceutical giant Pfizer will be paying more than $2.3 million on behalf of its wholly owned subsidiary ...
Unexpected demand for Pfizer Inc.’s Covid vaccine helped the company beat quarterly expectations. Then Robert F. Kennedy Jr., who has been a vocal opponent of the company’s top-selling shot ...
30, 2022. Pfizer announced its plans to acquire Biohaven Pharmaceuticals in May 2022. The pharmaceutical juggernaut’s largest manufacturing facility is in Portage, Michigan, which employs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results